Evofem Biosciences, Inc. (EVFM)
OTCMKTS
· Delayed Price · Currency is USD
0.0095
-0.0005 (-5.00%)
Dec 5, 2025, 3:50 PM EST
Evofem Biosciences Employees
Evofem Biosciences had 32 employees as of December 31, 2024. The number of employees decreased by 6 or -15.79% compared to the previous year.
Employees
32
Change (1Y)
-6
Growth (1Y)
-15.79%
Revenue / Employee
$553,938
Profits / Employee
-$173,594
Market Cap
1.22M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Elite Pharmaceuticals | 68 |
| Glass House Brands | 374 |
| CytoDyn | 13 |
| American Oncology Network | 1,914 |
| Northwest Biotherapeutics | 25 |
| Silence Therapeutics | 116 |
| Zomedica | 152 |
Evofem Biosciences News
- 14 days ago - Favorable Pricing Certificates Issued for Evofem's PHEXX by Emirates Drug Establishment are Launching Step for Commercialization in UAE - PRNewsWire
- 22 days ago - Evofem Reports Financial Results for Third Quarter of 2025, Provides Business Update - PRNewsWire
- 6 weeks ago - Evofem Announces Voting Results from Special Meeting of Stockholders - PRNewsWire
- 2 months ago - Evofem's SOLOSEC Submitted for Marketing Approval in United Arab Emirates - PRNewsWire
- 2 months ago - Evofem Biosciences Honors World Contraception Day - PRNewsWire
- 3 months ago - Evofem's "Say Vagina" Campaign Generates More than 2.5 Million Views Across Social Media Platforms - PRNewsWire
- 3 months ago - Evofem Anticipates Approval of Merger with Aditxt at Upcoming Stockholder Meeting - PRNewsWire
- 3 months ago - Illinois Pharmacists Can Prescribe PHEXXI Starting January 2026 Under Newly-passed Law - PRNewsWire